Royal Philips of the Netherlands is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Since the introduction of the first Philips light bulb more than 120 years ago, innovation and a people-centric approach have always been at the core of our company.
Philips commitment is to deliver new healthcare and lighting technologies, as well as innovative and locally relevant consumer products that make a real difference to our customers, consumers and stakeholders across the globe. We believe that the best way for us to do this, is through deep understanding of people’s needs and desires.
ASA has a promotional partnership with Philips and has received funding from them.
Philips Respironics is is the leader in sleep disordered breathing treatment options. They offer the DreamStation CPAP and the System One CPAP. They also offer several CPAP masks, including: DreamWear, Wisp, Wisp Pediatric, Amara View, Amara, Pico, and Nuance. Their DreamMapper app and web-based program offers interactive data and feedback on CPAP use.
Philips, Respironics, DreamStation, Portable CPAP, System One,DreamWear, Wisp, Wisp Pediatric, Amara View, Amara, Pico,Nuance, and DreamMapper are trademarks of Koninklijke Philips N.V. ASA has a promotional partnership with Philips and has received funding from them.
American Sleep Association® ASA does not provide medical advice, diagnosis or treatment. ASA has beneficial partnerships with corporations listed at: Terms of Use and Conditions, Privacy Policy
